Species-specific Inhibition of APOBEC3C by the Prototype Foamy Virus Protein Bet
Mario Perković(Paul Ehrlich Institut), Carsten Münk(Heinrich Heine University Düsseldorf), Ferdinand Kopietz(Paul Ehrlich Institut), Klaus Cichutek(Paul Ehrlich Institut), Henning Hofmann(New York University), Dirk Lindemann(University Hospital Carl Gustav Carus), Johannes Hermle(Berkeley College), Jörg Zielonka(Paul Ehrlich Institut), Benjamin Stauch(Goethe University Frankfurt), Stanislaw Schmidt(Paul Ehrlich Institut), Björn‐Philipp Kloke(BioNTech (Germany)), Vinay K. Pathak(National Cancer Institute), Daniela Marino(Paul Ehrlich Institut), Rebecca A Russell(University of Oxford), Heike A. Ströver(Paul Ehrlich Institut), Martin Löchelt(German Cancer Research Center), Gisbert Schneider(ETH Zurich)
Cited by 72
Related Papers
Designing antimicrobial peptides: form follows function
|Nature Reviews Drug Discovery|2011|2k
Patient Blood Management
|JAMA|2019|619
Predicting drug metabolism: experiment and/or computation?
|Nature Reviews Drug Discovery|2015|500